MUSK and myasthenia gravis: This result also demonstrates to some extend why anti-CD20 agents are particularly effective in improving symptoms in MuSK-MG patients, although the more important reason is that anti-MuSK antibodies are mainly produced by SLPBs (expressing CD20) (12, 32).